| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expenses) | -2,939 | -4,500 | -4,504 | -3,599 |
| Loss before provision for income taxes | -1,714,536 | -1,683,199 | -1,635,064 | -1,412,566 |
| Provision for income taxes | - | 0 | - | - |
| Net loss | -1,714,536 | -1,683,199 | -1,635,064 | -1,412,566 |
| Net loss per common share, basic | -0.98 | -0.97 | -0.97 | -0.06 |
| Net loss per common share, diluted | -0.98 | -0.97 | -0.97 | -0.06 |
| Weighted average common shares outstanding, basic | 1,757,900 | 1,739,045 | 1,686,144 | 24,442,853 |
| Weighted average common shares outstanding, fully diluted | 1,757,900 | 1,739,045 | 1,686,144 | 24,442,853 |
Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc. (CDIO)